Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Duyvesteyn HME. et al, (2024), Structure
Oligomerisation-driven avidity controls SARS-CoV-2 cellular binding and inhibition
Asor R. et al, (2024), Proceedings of the National Academy of Sciences of the United States of America
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: a prospective observational study in Vietnam.
Thanh TT. et al, (2024), Int J Infect Dis
The impact of exchanging the light and heavy chains on the structures of bovine ultralong antibodies.
Clarke JD. et al, (2024), Acta Crystallogr F Struct Biol Commun, 80, 154 - 163
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
POUWELS K. et al, (2024), Nature Communications
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Liu C. et al, (2024), Cell Rep Med
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Liu C. et al, (2024), Nat Commun, 15
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Michael BD. et al, (2024), Nat Commun, 15
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Zhou D. et al, (2024), Nat Commun, 15
Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023.
Chau NVV. et al, (2024), Emerg Infect Dis, 30, 363 - 367
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Jia W. et al, (2024), Nature Communications
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium.
Nhu LNT. et al, (2024), Wellcome Open Res, 9
Delayed mucosal anti-viral responses despite robust peripheral inflammation in fatal COVID-19.
Sidhu JK. et al, (2023), The Journal of infectious diseases, jiad590 - jiad590
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Michael BD. et al, (2023), Nat Commun, 14
Structural comparison of typical and atypical E2 pestivirus glycoproteins.
Aitkenhead H. et al, (2023), Structure
Production and characterisation of stabilised PV-3 virus-like particles using Pichia pastoris
Sherry L. et al, (2022)
Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study
Dunning W. and MERSON L., (2022), Nature